Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Apr 15, 2019; 11(4): 335-347
Published online Apr 15, 2019. doi: 10.4251/wjgo.v11.i4.335
Published online Apr 15, 2019. doi: 10.4251/wjgo.v11.i4.335
Clinical / pathological features | n |
Gender | |
Male | 718 |
Female | 477 |
Age (yr) | |
≤ 60 | 578 |
> 60 | 617 |
Tumor grade | |
G1 | 42 |
G2 | 857 |
G3 | 296 |
Tumor stage | |
pT1 | 32 |
pT2 | 175 |
pT3 | 937 |
pT4 | 51 |
Nodal status | |
pN0 | 593 |
pN1 | 296 |
pN2 | 306 |
Tumor type | |
Tubular carcinoma | 1089 |
Mucinous carcinoma | 106 |
Localization | |
Ascending colon | 273 |
Transverse colon | 32 |
Descending colon | 56 |
Sigmoid | 289 |
Rectum | 545 |
Total number | 1195 |
- Citation: Wang XY, Zheng ZX, Sun Y, Bai YH, Shi YF, Zhou LX, Yao YF, Wu AW, Cao DF. Significance of HER2 protein expression and HER2 gene amplification in colorectal adenocarcinomas. World J Gastrointest Oncol 2019; 11(4): 335-347
- URL: https://www.wjgnet.com/1948-5204/full/v11/i4/335.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i4.335